BIOC - Biocept Inc
Close
0.4349
-0.065 -15.015%
Share volume: 751,454
Last Updated: Tue 24 Oct 2023 10:00:00 PM CEST
Medical Laboratories :
-3.31%
PREVIOUS CLOSE
CHG
CHG%
$0.50
-0.07
-13.06%
Summary score
9%
Profitability
7%
Dept financing
4%
Liquidity
48%
Performance
2%
Sector
Health Care and Social Assistance
Industry
Medical Laboratories
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-132.08%
Return on assets
-48.49%
Return on sales
-524.85%
Return on invested capital
294.72%
Total debt ratio
61.4%
Debt ratio change over timeo
-0.72%
Current Ratio
2.24%
Quick Ratio
2.12%
Cash Position Ratio
1.71%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-46.66%
Return on assets
-27.72%
Return on sales
-453.4%
Return on invested capital
341.63%
Total debt ratio
32.13%
Debt ratio change over timeo
-0.91%
Current Ratio
3.46%
Quick Ratio
3.32%
Cash Position Ratio
2.66%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-24.88%
Return on assets
-19.49%
Return on sales
-701.24%
Return on invested capital
388.26%
Total debt ratio
21%
Debt ratio change over time
-0.94%
Current Ratio
5.16%
Quick Ratio
4.99%
Cash Position Ratio
4.27%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-165.91%
Return on assets
-120.59%
Return on sales
-298.99%
Return on invested capital
7.49%
Total debt ratio
-72.36%
Debt ratio change over time
-0.72%
Current Ratio
-0.15%
Quick Ratio
-0.19%
Cash Position Ratio
-0.34%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BIOC | PROG | MGEN | GTH |
|---|---|---|---|---|
| Return on equity | -132.08% | 164.69% | 82.72% | -43.6% |
| Return on assets | -48.49% | -36.2% | -20.15% | -8.91% |
| Return on sales | -524.85% | -209.68% | -216.63% | -78.82% |
| Return on invested capital | 294.72% | 57% | 135.75% | 1234.56% |
| Profitability | 6% | 26% | 15% | 75% |
| Total debt ratio | 61.4% | 142.81% | 32.08% | 277.44% |
| Debt ratio change over time | -0.72% | 2% | -0.73% | 0.1% |
| Dept financing | 6% | 38% | 3% | 26% |
| Current Ratio | 3.46% | 1.41% | 3.97% | 4.56% |
| Quick Ratio | 3.32% | 1.29% | 0% | 4.47% |
| Cash Position Ratio | 2.66% | 0.68% | 3.39% | 3.36% |
| Liquididy | 26% | 15% | 59% | 54% |
| Short-term ratios | BIOC | PROG | MGEN | GTH |
|---|---|---|---|---|
| Return on equity | -46.66% | 164.69% | -43.22% | -43.6% |
| Return on assets | -27.72% | -36.2% | -25.36% | -8.91% |
| Return on sales | -453.4% | -291.36% | 0% | -70.57% |
| Return on invested capital | 341.63% | 57% | 108.1% | 1234.56% |
| Profitability | 7% | 26% | 27% | 50% |
| Total debt ratio | 32.13% | 142.81% | 38.97% | 277.44% |
| Debt ratio change over time | -0.91% | 2% | -0.64% | 0.1% |
| Dept financing | 3% | 38% | 4% | 26% |
| Current Ratio | 3.46% | 1.41% | 3.97% | 4.56% |
| Quick Ratio | 3.32% | 1.29% | 0% | 4.47% |
| Cash Position Ratio | 2.66% | 0.68% | 3.39% | 3.36% |
| Liquididy | 57% | 20% | 47% | 75% |